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Autoradiography of inhibitory and excitatory amino acid neurotransmitter binding sites in the cervical spinal cord of M. fascicularis spinal cord 
revealed inhomogeneous distribution of all binding sites in spinal gray matter. Quisqualate-sensitive [3H]glutamate binding, [3H]MK-801 binding, 
benzodiazepine binding, kainate binding, and GABA B binding had highest levels in the superficial layers of the dorsal horn (laminae 1 and 2) 
and substantially lower levels in other laminae. [3H]Strychnine binding was more uniformly distributed throughout all laminae with highest levels 
in the superficial layers of the dorsal horn. These results are similar to those found in other mammals. 
Excitatory amino acids (EAAs) and the inhibitory 
amino acids, gamma-aminobutyric acid (GABA) and 
glycine (GLY), are important neurotransmitters within 
the spinal cord. EAAs are known to be neurotransmit- 
ters of primary afferents and descending projections 
from the brain6,16,17,24,301, and may be neurotrans- 
mitters of some intrinsic spinal neurons H'2°. GABA 
and GLY are the neurotransmitters of populations of 
spinal interneurons t5'26-29. 
An important facet of both EAA- and GABA-medi-  
ated neurotransmission is the existence of receptor 
subtypes with distinctive pharmacologic and physologic 
properties. Four types of pharmacologically defined 
EAA receptors and two types of GABA receptors are 
recognized 4,7,13,31. Among ionotropic EAA receptors, 
the N-methyl-D-aspartate (NMDA) receptor is distin- 
guished by long latency, long duration depolarizations 
and voltage-dependent  activation. N M D A  receptors 
possess additional modulatory s i tes /b inding sites for 
glycine, polyamines, and dissociative anesthetics. The 
a-amino-3-hydroxy-5-methylisoxazole-4-propionic acid 
(AMPA) and kainate (KA) receptors are ionotropic 
receptors mediating conventional fast neurotransmis- 
sion. The metabotropic E A A  receptor is a G-protein 
coupled receptor linked to inositol phospholipid 
metabolism. Both the MET and A M P A  receptors are 
activated by quisqualate. Two types of GABA recep- 
tors are recognized. The GABA_ A receptor is a het- 
eroligomeric ionotropic receptor with additional modu- 
la tory/binding sites for benzodiazepines (BDZ) and 
other compounds. The GABA_ B receptor is a G-pro- 
tein coupled receptor linked to modulation of ion 
channels and second messenger systems. Cloning of 
EAA and GABA_ A receptors have added another  
level of complexity to the classification of these recep- 
tors by revealing a wealth of different proteins underly- 
ing the prior pharmacological classification schemes. 
Prior studies have described the distribution of EAA, 
GABA, and GLY binding sites in rodent, human, and 
cat spinal cord 2'8'9'12'14'18'19'29'32. Non-human primates 
are used frequently for studies of spinal and sensory 
function, but no study has described the distribution of 
these binding sites in non-human primate spinal cord. 
We used receptor autoradiography to describe the 
distribution of EAA, GABA, and GLY binding sites in 
the cervical spinal cord of the cynomolgus monkey (M. 
f ascicularis ). 
Six cynomolgus monkeys were anesthetized, sacri- 
ficed with cardioplegic doses of intravenous KCI, and 
the brain and spinal cord were extracted as described 
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TABLE I 
EAA, GABA, and GLY binding sites assays 
Site Ligand S.A. Conc. Buffer Blockers Blank 
Quisqualate- [3H]glutamate 48 Ci/mmol 20 nM 50 mM Tris-HCl 1 mM NMDA 2.5/zM 
sensitive + 2.5/~M CaCI 2 quisqualate 
glutamate pH 7.2 
NMDA [3H]MK-801 15 Ci/mmol 20 nM 50 mM Tris-Ac - 5/zM MK-801 
pH 7.4 
Kainate [3H]kainate 6 Ci/mmol 60 nM 50 mM Tris-Ac - 100/~M kainate 
pH 7.2 
GABA_ A [3H]flunitrazepam 85 Ci/mmol 5 nM 50 mM Tris-Cit 2/zM clonazepam 
pH 7.0 
GABA_ B [3H]GABA 105 Ci/mmol 20 nM 50 mM Tris-HC1 10/~M isoguvacine 100/~M baclofen 
Glycine [3H]strychnine 17 Ci/mmol 26 nM 50 mM KNaPO 4 24 mM glycine 
previously 23. Brains and spinal cords were frozen by 
immersion in isopentane cooled with liquid nitrogen, 
coated with embedding matrix and stored at -70°C. 
All animals were controls for a study of the effects of 
cerebral cortical ablation on motor performance. All 
animals received intravenous [14C]deoxyglucose prior 
to death 23. Prewash steps removed the [14C]deoxyglu- 
cose and prevented it from interfering with analysis of 
binding data. 
At the time of assay, spinal cords were warmed to 
-20°C overnight and 1-cm blocs were taken at the 
middle of the cervical enlargement. Twenty-micron 
frozen sections were cut on a Lipshaw cryostat and 
thaw mounted onto gelatin-coated slides. Sections were 
stored at -20°C until the time of assay (24-72 h). 
Closely adjacent sections were fixed over paraformal- 
dehyde vapor for 48-72 h and stained with 0. 5% 
Cresyl violet. 
EAA, GABA, and GLY binding sites were assayed 
with conventional techniques (Table I). All assays were 
run in duplicate or triplicate. Quisqualate-sensitive 
[3H]glutamate binding (a combined measure of AMPA 
and MET binding sites) 3, GABA_ B binding 5, and 
[3H]kainate binding TM were all performed in a similar 
manner. Sections received 3 × 10 min prewashes in 
buffer at 4°C, dried under a stream of cool air, and 
immersed in cytomailers containing buffer (4°C) with 
radioactive ligand and appropriate blocking agents. 
After 45 min, incubations were terminated with 3 
(GABA_ B assay) or 4 ([3H]glutamate and [3H]kainate) 
rapid 4-ml squirts of buffer (4°C) from a repipettor 
followed by 1 (GABA_ B) or 2 ([3H]glutamate and 
[3H]kainate) rapid 3 ml squirts of 2.5% acetone in 
glutaraldehyde, and dried under a stream of hot air. 
NMDA binding sites were assayed with [3H]MK-801 
according to the method of Sakurai et al. 21 (Table 1). 
Sections received 3 × 10 min prewashes in buffer (4°C), 
dried under a stream of cool air, and immersed in 
ligand solution for 2 h at room temperature. Incuba- 
tion was terminated by washing sections for 80 min in 
buffer (4°C) and sections were dried under a stream of 
hot air. 
GABA_ A binding sites were assayed by determining 
BDZ binding with [3H]flunitrazepam3. Sections re- 
ceived 3 × 10 min prewashes in buffer (4°C), and then 
were dried under a stream of cool air, and immersed in 
ligand solution (4°C) for 30 min. Incubation was termi- 
nated by one quick dip in buffer (4°C) followed by 
2 x 5 min rinses in buffer (4°C), and then sections were 
dried under a stream of hot air. 
TABLE II 
EAA, GABA, and GLY  binding site levels in cynomolgus monkey cervical spinal cord 
All values in fmol/mg prot (S.E.M.). SDH = superficial dorsal horn, DDH = deep dorsal horn, IH = intermediate region, VH = ventral horn 
Binding site SDH DDH IH VII 
Quisqualate- 30 (6.4) * 4.65 (1.6) 2.7 (1.7) 2.4 (1.8) 
sensitive 
glutamate 
NMDA 218.2 (14.4) * 68.2 (5.8) 63 (4.1) 60.3 (5.2) 
Kainate 364.9 (16.8) * 68.9 (5.9) ** 36.9 (4) 18.9 (4.9) 
GABA_ A 227.4 (16.4) * 110.6 (10.7) ** 86.3 (9.4) 73.9 (8.7) 
GABA_B 61.2 (12.2) * 16.2 (5.4) 9.4 (4.1) 7.5 (3.6) 
Glycine 3364 (69)* 2198 (140) 2206 (121) 2302 (74) 
* Significantly different than DDH, IH, VH (P < 0.05). 
* * Significantly different than IH, VH (P < 0.05). 
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To assay GLY sites, [-~H]strychnine binding was 
performed 32. Sections received 3 × 10 min prewashes 
in buffer (4°C) and dried under a stream of cool air, 
and then incubated in ligand solution (4°C) for 30 min. 
Incubation was terminated with 4 quick dips in buffer 
(4°C) followed by one quick dip in distilled water. 
Sections were dried under a stream of hot air. 
Slides were apposed to tritium sensitive film (Hyper- 
film, Amersham) and exposed along with standards 
containing known amounts of radioactivity (ARC, St 
Louis, MO) for 1-3 weeks. Films were developed in 
D-19 (Kodak) and binding levels were quantitated with 
computer assisted densitometry using the MCID sys- 
tem (Imaging Research, St. Catharines, ONT). Regions 
read included the superficial dorsal horn (SDH), com- 
prising laminae 1 and 2; the deep dorsal horn (DDH), 
comprising laminae 3 to 5; the intermediate region 
(IN), comprising lamina 6, lamina 10, and part of 
lamina 7; and the ventral horn (VH). Assignment of 
regions was made by referring to Cresyl violet-stained 
sections. Binding site levels across regions were com- 
i 
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Fig. 1. Excitatory and inhibitory amino acid neurotransmit ter  recep- 
tor binding sites in the cynomologus monkey cervical spinal cord. A 
quisqualate-sensitive [3H]glutamate binding. B [3H]MK-801 binding. 
C [3H]kainate binding. D [3H]Flunitrazepam binding. E G A B A _  B 
binding. F [3H]Strychnine binding. SDH = superficial dorsal horn 
(laminae l and 2), DDH = deep dorsal horn (laminae 3-5),  IH = 
intermediate spinal gray (laminae 6, 10 and part of 7), VH = ventral 
horn. Bar = 2 mm. 
pared with a one-factor ANOVA using the Statview I1 
program (Abacus Concepts, Berkeley, CA) followed by 
Fisher's PLSD test for post-hoc individual compar- 
isons. 
Data analysis revealed that all binding sites had a 
heterogeneous distribution within the spinal gray mat- 
ter (Table II, Fig. 1). Quisqualate-sensitive [3H]gluta- 
mate binding, [3H]kainate binding, BDZ binding, 
GABA n binding, and [3H]MK-801 binding were all 
concentrated within the SDH with significantly lower 
levels of binding in other regions (Table II, Fig. 1). The 
IN and VH had especially low levels of all binding sites 
(Table II, Fig. 1). BDZ binding and [3H]kainate bind- 
ing had higher levels in the DDH than the IX or VH. 
GLY binding sites were more homogeneously dis- 
tributed with substantial levels of [3H]strychnine bind- 
ing in all regions (Table II, Fig. 1). Nonetheless, GLY 
binding site levels were. highest in the SDH (Table II, 
Fig. 1). 
These results are similar to prior results of binding 
studies in rat, mouse, cat, and human spinal cord. In 
all cases, both EAA and GABA binding sites have 
been found to be concentrated in the superficial dorsal 
horn, especially lamina 2 2'9'12'14'18"29. similarly, GLY 
binding sites have been found to be more evenly dis- 
tributed throughout the spinal gray, though highest 
levels are generally found in the superficial dorsal 
horn 8'19'32. For EAA binding sites, these data are simi- 
lar to the results of Tallaksen-Greene et al. in the 
trigeminal nucleus, the brainstem homologue of the 
dorsal horn 25. 
These results also have some correlation with the 
distribution of EAAs and GABA within the spinal 
cord. EAAs are neurotransmitters released by primary 
and descending afferents, which have extensive termi- 
nal arborizations within the S D H  6'16'17'24"30. Intrinsic 
EAAergic spinal neurons may also be concentrated 
within laminae 1 and 211'2°. These results also correlate 
well with electrophysiologic data showing that EAA-re- 
sponsive dorsal horn neurons are concentrated in the 
superficial laminae, where they may play a particularly 
important role in the transfer of nociceptive informa- 
tion to the central n e r v o u s  s y s t e m  1'22'24. The distribu- 
tion of GABAergic innervation also has some correla- 
tion with the distribution of G A B A  A and GABA_ 
binding sites. Spinal GABAergic interneurons are 
abundant within the superficial laminae, particularly 
within laminae 1 and 2 15"27'29. Glutamic acid decarbox- 
ylase immunoreactivity is concentrated within the su- 
perficial layers of the dorsal horn, with highest density 
in laminae 2 and high levels in both laminae 3 and 4 ~5 
GABA B receptors are found both as postsynaptic re- 
ceptors on neurons within the superficial laminae of 
dorsal neurons and as presynaptic heteroreceptors on 
the terminals of primary afferents within the dorsal 
hornl0, TM. 
The distribution of GLY binding sites does not, 
however, match precisely the distribution of GLYiner- 
gic neuronal elements in the spinal cord. While GLY- 
immunoreactive neurons and neuropil are found 
throughout the spinal gray, GLY-immunoreactive neu- 
rons and neuropil tend to have lower density in lami- 
nae 1 and 2, a distribution somewhat different than 
that found with [3H]strychnine binding z6'27'28. 
Other neurotransmitter/neuromodulator receptor 
binding sites have been found to be concentrated within 
the SDH. The concentration of different neurotrans- 
mitter receptor binding sites within the superficial dor- 
sal horn indicates that processing of afferent input 
within this region is likely to be complex. 
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